易大宗(01733.HK):可換股債券轉換價調整至每股0.604港元
格隆匯9月25日丨易大宗(01733.HK)公佈,有關發行本金總額4000萬美元的債券1.18億份認股權證以及轉換價及認股權證認購價的調整。有關債券的轉換價應由每股換股股份0.72港元調整至每股換股股份0.604港元。
於公告日期,債券的未償還本金額為3000萬美元。轉換價調整後,債券賦予其持有人有權將未償還債券轉換成3.86億換股股份。換股股份將根據特別授權發行及配發。公司有權發行及配發公司於債券所附帶之換股權獲行使後須予發行及配發之有關公司股份數目,且於公告日期,公司尚未悉數行使特別授權。
此外,有關認股權證認購價應由每股認股權證股份0.908港元調整至每股認股權證股份0.761港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.